Acute Porphyria Drug Database

R03AC12 - Salmeterol
Propably not porphyrinogenic
PNP

Rationale
Substrate for CYP 3A4. Probably insignificant metabolic load.
Chemical description
(To be edited, initial data ST OCT 04) Adrenergic administered in asthma in inhalation aerosol, 50 µg/dose. Gives rise only to very low plasma concentrations. Metabolized in the liver (CYP 3A4) producing several metabolites.
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes R03A / R03AC or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙